All In MedTech

Device Trial Radar · NCT05675371

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

A Prospective, Multi-Center, Longitudinal Study of Dynamic Quantification of Social-Visual Engagement (DQSVE) For Treatment Monitoring In Children With Autism Spectrum Disorder (ASD).

Last checked: Nov 20, 2026Latest source record: Sep 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

325

Actual

Start

Mar 31, 2023

Primary completion

Sep 8, 2025

Study completion Sep 8, 2025

Sponsor

Lead sponsor
EarliTec Diagnostics, IncNot on our public-company list
Sponsor type
Industry
First posted
Jan 9, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 15 months, up to 84 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical study is to learn about the utility and performance of the EarliPoint(™) System: Evaluation for Autism Spectrum Disorder to monitor changes in a child's verbal ability, non-verbal learning, and social disability over time in children ages 15-84 months with autism spectrum disorder or related developmental delays (DD) and in those who are typically developing. The main questions it aims to answer are: * To estimate the change in each of the EarliPoint index scores in typically developing children ages 15-84 months from baseline through 180 days as a function of the child's age. * To estimate the change in the EarliPoint verbal and non-verbal index scores in ASD/DD children ages 15-84 months from baseline through 180 days as a function of the child's age in: a) those who showed clinical improvement, and b) those who did not show clinical improvement. * To estimate the relationship of the EarliPoint verbal and non-verbal index scores to clinical reference assessments in ASD/DD children as a function of their age from baseline through 180 days. * To estimate the degree of change, if change occurs, month-to-month in the EarliPoint Social Disability Index score from baseline through 180 days. * To estimate the incidence of behavioral events (e.g., tantrums, etc.) which limit the subject from completing an eye-tracking session. * To estimate the incidence of adverse device effects associated with the use of the study device.

Conditions

  • Autism Spectrum Disorder
  • Autism
  • Developmental Delay
  • Autism, Early Infantile
  • Autism, Infantile

Interventions

  • Assessment by Expert Clinician During Behavioral Intervention (ABA or similar)Behavioral

    Assessment (e.g., responder vs. non-responder status) utilizing gold-standard clinical reference assessments performed by expert clinicians as the subject undergoes Applied Behavioral Analysis (ABA) or similar intervention for autism spectrum disorder and related developmental delays

  • Assessment by the EarliPoint Assessment For Autism Spectrum DisorderDevice

    Assessment by The EarliPoint™ Evaluation for Autism Spectrum Disorder (ASD), a medical device which employs Dynamic Quantification of Social-Visual Engagement (DQSVE) to aid clinicians in the diagnosis, assessment, and treatment monitoring of ASD related developmental delays, is a diagnostic tool which measures an individual's visual preferential attention to social information in the environment relative to normative age-specific benchmarks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in EarliPoint Index Scores in typically developing childrenTime frame: 180 days
  2. Change in EarliPoint Index Scores in ASD/DD childrenTime frame: 180 days

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Southwest Autism Research and Resource Center (SARRC)

    Phoenix, Arizona

  • Cortica - Glendale

    Glendale, California

  • Cortica - Marin

    San Rafael, California

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.